0.304
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NovaBay Pharmaceuticals Inc New | NBY | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.304 | 04:36:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.304 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.1711 - 0.77 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.304 | USD |
Period:
Draw Mode:
NovaBay Pharmaceuticals Inc New Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 16.00M | 52.62M | 46.73M | $ 8.42M | $ -3.03M | -0.15 | -3.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 4.20% |
NovaBay Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NBY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.261 | 0.361 | 0.2512 | 0.3208147 | 2,028,417 | 0.043 | 16.48% |
| 1 Month | 0.27 | 0.361 | 0.21 | 0.2923452 | 839,810 | 0.034 | 12.59% |
| 3 Months | 0.1996 | 0.361 | 0.1802 | 0.2547565 | 774,288 | 0.1044 | 52.3% |
| 6 Months | 0.3258 | 0.361 | 0.1711 | 0.2598692 | 584,562 | -0.0218 | -6.69% |
| 1 Year | 0.6151 | 0.77 | 0.1711 | 0.418496 | 725,363 | -0.3111 | -50.58% |
| 3 Years | 1.05 | 2.18 | 0.1711 | 0.9555548 | 2,089,000 | -0.746 | -71.05% |
| 5 Years | 4.60 | 4.80 | 0.1711 | 1.09 | 1,409,562 | -4.30 | -93.39% |
NovaBay Pharmaceuticals Description
| NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. |